Last updated: February 29, 2024
Sponsor: Shandong Linglong Yingcheng Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Liver Disorders
Gall Bladder Disorders
Treatment
Bifidobacterium group
Ursodoxycholic acid group
Clinical Study ID
NCT06287931
sdllycyy001
Ages 20-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients receiving bariatric surgery for morbid obesity
- Patiets at ages between 20 to 60 y/o
- Patients willing to follow up regulary after bariatric surgery
Exclusion
Exclusion Criteria:
- Patients having gallstones before bariatric surgery
- Patients refusing taking probiotics or refusing regular follow up after bariatricsurgery
Study Design
Total Participants: 400
Treatment Group(s): 2
Primary Treatment: Bifidobacterium group
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
June 01, 2025
Connect with a study center
Shandong Linglong Yingcheng Hospital
Yantai, Shandong 264000
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.